XML 46 R36.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stockholders' equity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Jul. 14, 2015
May. 08, 2015
May. 31, 2015
Oct. 24, 2014
Mar. 31, 2014
Mar. 31, 2016
Dec. 31, 2015
Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Allocated Share-based Compensation Expense           $ 261,497   $ 590,603
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           30,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price           $ 1.53    
Proceeds From Issuance Of Units Under Initial Public Offering Gross   $ 17,100,000            
Proceeds From Issuance Of Units Under Initial Public Offering Net   $ 12,100,000            
Common Stock, Shares Authorized           200,000,000 200,000,000  
Common Stock, Shares, Issued           12,576,306 12,547,644  
Preferred Stock, Shares Authorized           10,000,000 10,000,000 10,000,000
Over-Allotment Option [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   3,272,500            
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 6.60            
Expiration Date of Warrants Issued   May 08, 2020            
IPO [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Debt Conversion, Converted Instrument, Amount   $ 2,100,000            
Debt Conversion, Converted Instrument, Shares Issued   350,000 1,875,000          
Demand Notes Payable [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Debt Conversion, Converted Instrument, Amount   $ 2,100,000            
2015 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized           1,355,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant           748,479    
Share-based Compensation Arrangement by Share-based Payment Award, Common stock Percentage           4.00%    
2015 Plan | January 1, 2016 [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant           501,907    
Stock options                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value           $ 0.73    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number           2,119,140    
Restricted stock units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period         130,640   75,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value             $ 1.70  
Common Stock [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock and Warrants Issued in Conjunction with Initial Public Offering   2,850,000            
Offering Price Per Unit   $ 6.00            
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 2,900,000            
Warrants Issued During Period On Exercise Of Over Allotment Option Shares   422,500            
Proceeds from Issuance of Warrants   $ 4,225            
Convertible Preferred Stock, Shares Issued upon Conversion   7,374,852            
Shares Of Stock Issued For Restricted Stock Unit Exercises       130,640        
Common Stock [Member] | Merck Global Health Innovation Fund LLC [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock Issued During Period, Shares, New Issues 1,136,364              
Offering Price Per Unit $ 4.40              
Proceeds from Issuance of Common Stock $ 5,000,000              
Common Stock [Member] | Over-Allotment Option [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   185,250            
Common Stock [Member] | IPO [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Debt Conversion, Converted Instrument, Shares Issued     350,000